{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:41:30Z","timestamp":1767987690377,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4986,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.fertnstert.2007.07.1348","type":"journal-article","created":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T07:21:03Z","timestamp":1190272863000},"page":"965-971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy"],"prefix":"10.1016","volume":"90","author":[{"given":"Kavita","family":"Nanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Hays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.M.","family":"Viscola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Bahamondes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2007.07.1348_bib1","first-page":"3297","article-title":"Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate","volume":"6","author":"Kobayashi","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib2","article-title":"Recomenda\u00e7\u00f5es para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV","author":"Brasil Minist\u00e9rio da Sa\u00fade","year":"2006","journal-title":"Bras\u00edlia: Brasil Minist\u00e9rio da Sa\u00fade"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib3","unstructured":"U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents [monograph]. Available at: http:\/\/aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf. Accessed November 30, 2006."},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib4","unstructured":"World Health Organization. Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach [monograph]. April 2002. Available at: http:\/\/www.who.int\/hiv\/topics\/arv\/scaling_exe_summary.pdf. Accessed November 30, 2006."},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib5","unstructured":"Gilead Sciences. Tenofovir prescribing information. Available at: http:\/\/www.gilead.com\/pdf\/viread_pi.pdf. Accessed November 30, 2006."},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2125.1998.00749.x","article-title":"Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers","volume":"46","author":"Ouellet","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00042560-200204150-00007","article-title":"Pharmacokinetic interaction between nevirapine and ethinyl estradiol\/norethindrone when administered concurrently to HIV-infected women","volume":"29","author":"Mildvan","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/aje\/kwi116","article-title":"Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy","volume":"161","author":"Chu","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.qai.0000219777.04927.50","article-title":"Tolerance and acceptability of an efavirenz-based regimen in 740 adults (predominantly women) in West Africa","volume":"42","author":"Danel","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02987102","article-title":"Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate","volume":"7","author":"Halpenny","year":"1990","journal-title":"Med Oncol Tumor Pharmacother"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00689091","article-title":"Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer","volume":"27","author":"Lundgren","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1783\/1471189041261393","article-title":"The members' enquiry service: frequently asked questions","volume":"30","author":"De Souza","year":"2004","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib13","unstructured":"Scottish Intercollegiate Guidelines Network. Guideline no. 70: diagnosis and management of epilepsy in adults [monograph]. Available at: http:\/\/www.sign.ac.uk\/guidelines\/fulltext\/70\/index.html. Accessed November 30, 2006."},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib14","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products\u2014general considerations [monograph]. Available at: http:\/\/www.fda.gov\/cder\/guidance\/5356fnl.pdf. Accessed November 30, 2006."},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.contraception.2004.07.001","article-title":"Factors associated with reproductive options in HIV-infected women","volume":"71","author":"da Silveira Rossi","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.olq.0000194602.01058.e1","article-title":"The value of contraception to prevent perinatal HIV transmission","volume":"33","author":"Reynolds","year":"2006","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.clpt.6100040","article-title":"Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions","volume":"81","author":"Cohn","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem-44-1-32","article-title":"Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA","volume":"44","author":"Ortiz","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0022-4731(78)90631-3","article-title":"A radioimmunoassay for serum medroxyprogesterone acetate","volume":"9","author":"Shrimanker","year":"1978","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0277-5379(90)90624-3","article-title":"Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer","volume":"26","author":"Karkkainen","year":"1990","journal-title":"Eur J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2007.07.1348_bib21","first-page":"3","article-title":"A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate","volume":"1","author":"Fraser","year":"1981","journal-title":"Med J Aust"},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib22","unstructured":"Pharmacia Limited. Depo-Provera\u00ae 150 mg\/ml summary of product characteristics. Available at: http:\/\/emc.medicines.org.uk\/eMC\/assets\/c\/html\/DisplayDoc.asp?DocumentID=11121. Accessed November 30, 2006."},{"key":"10.1016\/j.fertnstert.2007.07.1348_bib23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1210\/jcem-48-5-816","article-title":"In vivo metabolism of progestins. V. The effect of protocol design on the estimated metabolic clearance rate and volume of distribution of medroxyprogesterone acetate in women","volume":"48","author":"Gupta","year":"1979","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207029998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207029998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:30:57Z","timestamp":1758007857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028207029998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0015028207029998"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.07.1348","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.07.1348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}